NVST as reported
Envista Holdings Corporation reported $2.81B of revenue over the trailing twelve months, +12% on the year before. 11 reported series are charted on this page, each one as filed.
$2.81B
Revenue, trailing twelve months · to Q1 2026 · +12% against the twelve months before
- Net Income
- $68M
Net Income · −106% year on year · trailing twelve months to Q1 2026
- Free Cash Flow
- $220M
Free Cash Flow · −18% year on year · trailing twelve months to Q1 2026
- Op Margin
- 8.5%
Op Margin · trailing twelve months to Q1 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $2.81B | +12% | Q1 2026 |
| Net Income | $68M | −106% | Q1 2026 |
| EPS | $0.41 | −106% | Q1 2026 |
| Gross Margin | 55% | n/a | Q1 2026 |
| Op Margin | 8.5% | n/a | Q1 2026 |
| Net Margin | 2.3% | n/a | Q1 2026 |
| ROE | 1.5% | n/a | Q1 2026 |
| ROA | 0.82% | n/a | Q1 2026 |
| ROIC | 4.6% | n/a | Q1 2026 |
| Free Cash Flow | $220M | −18% | Q1 2026 |
| P/E | 67.8 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Envista Holdings Corporation (NVST) - Revenue & ProfitRevenue & ProfitEnvista Holdings Corporation (NVST)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Medical Instruments & Supplies
Ranks #8 of 27 by Smart Score